EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Acute intranasal treatment with nerve growth factor limits the onset of traumatic brain injury in young rats

Luigi Manni, Eleonora Leotta, Ilia Mollica, Annalucia Serafino, Annabella Pignataro, Illari Salvatori, Giorgio Conti, Antonio Chiaretti, Marzia Soligo iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Luigi Manni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Pharmacology, National Research Council of Italy (CNR), Rome, Italy. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Brain Injuries. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Traumatic brain injury (TBI) comprises a primary injury directly induced by impact, which progresses into a secondary injury leading to neuroinflammation, reactive astrogliosis, and cognitive and motor damage. To date, treatment of TBI consists solely of palliative therapies that do not prevent and/or limit the outcomes of secondary damage and only stabilize the deficits. The neurotrophin, nerve growth factor (NGF), delivered to the brain parenchyma following intranasal application, could be a useful means of limiting or improving the outcomes of the secondary injury, as suggested by pre‐clinical and clinical data. Experimental Approach We evaluated the effect of acute intranasal treatment of young (20‐postnatal day) rats, with NGF in a TBI model (weight drop/close head), aggravated by hypoxic complications. Immediately after the trauma, rats were intranasally treated with human recombinant NGF (50 μg·kg −1 ), and motor behavioural test, morphometric and biochemical assays were carried out 24 h later. Key Results Acute intranasal NGF prevented the onset of TBI‐induced motor disabilities, and decreased reactive astrogliosis, microglial activation and IL‐1β content, which after TBI develops to the same extent in the impact zone and the hypothalamus. Conclusion and Implications Intranasal application of NGF was effective in decreasing the motor dysfunction and neuroinflammation in the brain of young rats in our model of TBI. This work forms an initial pre‐clinical evaluation of the potential of early intranasal NGF treatment in preventing and limiting the disabling outcomes of TBI, a clinical condition that remains one of the unsolved problems of paediatric neurology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticBrain InjuriesChildRatsHumansAnimalsNerve Growth FactorNeuroinflammatory DiseasesGliosisInflammationDisease Models, Animal

Stichwörter der Autor:innen

intranasal deliverymicrogliamotor dysfunctionsnerve growth factorpaediatric ratreactive astrogliosistraumatic brain injury

Substanzen

Nerve Growth Factor

Autor:innen und Institutionen

  • Institute of Translational Pharmacology, National Research Council of Italy (CNR), Rome, Italy.
  • IRCCS Fondazione Santa Lucia, Rome, Italy.
  • Department of Experimental Medicine, Faculty of Medicine, University of Rome 'La Sapienza', Rome, Italy.
  • Intensive Pediatric Therapy and Pediatric Trauma Center, Department of Emergency, Anesthesiological and Reanimation Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Institute of Pediatrics, Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

ORCID-Profile: Marzia Soligo

Zitieren

APA

Manni, L., Leotta, E., Mollica, I., Serafino, A., Pignataro, A., Salvatori, I., Conti, G., Chiaretti, A., & Soligo, M. (2023). Acute intranasal treatment with nerve growth factor limits the onset of traumatic brain injury in young rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.16056

Vancouver

Manni L, Leotta E, Mollica I, Serafino A, Pignataro A, Salvatori I, et al. Acute intranasal treatment with nerve growth factor limits the onset of traumatic brain injury in young rats. British Journal of Pharmacology. 2023. doi:10.1111/bph.16056

BibTeX
@article{Manni2023,
  author = {Manni, Luigi and Leotta, Eleonora and Mollica, Ilia and Serafino, Annalucia and Pignataro, Annabella and Salvatori, Illari and Conti, Giorgio and Chiaretti, Antonio and Soligo, Marzia},
  title = {Acute intranasal treatment with nerve growth factor limits the onset of traumatic brain injury in young rats},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16056}
}
Kostenlos starten →